Treatment of Low Albumin and Protein
The primary treatment for low albumin and protein is identifying and treating the underlying cause—most commonly inflammation, fluid overload, or protein losses—rather than attempting to correct the albumin level itself through supplementation or infusion. 1, 2
Understanding the Pathophysiology
The most critical concept in managing hypoalbuminemia is recognizing that inflammation is the predominant cause of low albumin in most hospitalized patients, not malnutrition. 1 Inflammatory cytokines directly downregulate hepatic albumin synthesis even when protein and caloric intake are adequate. 1, 2 C-reactive protein and other acute-phase reactants are inversely correlated with serum albumin levels. 1
Other important causes include:
- Fluid overload (hemodilution) - excess crystalloid administration dilutes serum albumin concentration 1, 3
- External protein losses - nephrotic syndrome, protein-losing enteropathy, chronic kidney disease 1, 4
- Liver dysfunction - impaired albumin synthesis in severe end-stage liver disease 1, 5
Diagnostic Approach
Initial Assessment
Measure inflammatory markers (CRP, ESR) to distinguish inflammation-driven hypoalbuminemia from pure malnutrition. 1, 2 This is the single most important diagnostic step, as it fundamentally changes management.
Evaluate hydration status carefully - look for signs of volume overload including peripheral edema, ascites, pulmonary congestion, and recent crystalloid administration history. 1, 3
Quantify external protein losses:
- 24-hour urine protein or spot urine protein-to-creatinine ratio 6, 4
- Stool studies if protein-losing enteropathy suspected 1
Assess liver synthetic function with PT/INR, bilirubin, and other liver function tests. 1, 5
Primary Treatment Strategy
1. Treat the Underlying Cause
For inflammation: Address the primary inflammatory condition (infection, autoimmune disease, malignancy). 1, 2 Treating active inflammation is often more powerful for improving outcomes than the low albumin itself. 2
For fluid overload: Initiate diuretic therapy to remove excess fluid and correct hemodilution. 1, 2 Loop diuretics such as furosemide are appropriate. 4
For protein losses:
- Nephrotic syndrome: ACE inhibitors or ARBs to reduce proteinuria 4
- Consider disease-specific immunosuppression based on kidney biopsy findings 4
- In chronic kidney disease with proteinuria, ACE inhibitors or ARBs are recommended 6
For liver disease: Manage the underlying liver condition and complications. 5
2. Optimize Nutritional Support
Provide adequate protein intake:
- General hospitalized patients: 1.2-1.3 g/kg body weight/day minimum 2
- Hemodialysis patients: At least 1.2 g/kg/day 2
- Peritoneal dialysis patients: At least 1.3 g/kg/day due to dialysate protein losses 2
- Bariatric surgery patients: 60-80 g/day or 1.1-1.5 g/kg ideal body weight 6
Ensure adequate caloric intake:
High-protein food sources to emphasize: 2
- Lean meats (chicken, turkey, lean beef, pork) - 20-25g protein per 3-4 oz serving
- Fish and seafood (salmon, tuna, cod, shrimp)
- Eggs and dairy products
- Legumes and soy products
- Nuts and seeds
Important Caveat for Nephrotic Syndrome
In nephrotic syndrome specifically, high dietary protein supplementation is NOT recommended. 7, 8 Research demonstrates that increasing dietary protein in nephrotic patients increases glomerular permeability and albuminuria, causing further albumin pool depletion despite increased synthesis. 7, 8 Instead, protein restriction to 0.8 g/kg/day actually preserves total albumin mass and increases plasma albumin concentration by reducing urinary albumin losses. 8
When Albumin Infusion May Be Considered
Albumin infusion is NOT recommended for routine treatment of hypoalbuminemia. 2 The American College of Physicians and American Thoracic Society explicitly recommend against using IV albumin as first-line volume replacement or to increase serum albumin levels in critically ill patients. 2
Specific Indications for Albumin Infusion
Liver disease with complications:
- Large-volume paracentesis (>5L): 8 grams albumin per liter of ascites removed 2, 5
- Spontaneous bacterial peritonitis: 1.5 g/kg on day 1, then 1.0 g/kg on day 3 2, 5
- Hepatorenal syndrome-AKI: 1 g/kg day 1, then 20-40 g daily with vasopressors 2
Congenital nephrotic syndrome: Daily albumin infusions of 1-4 g/kg based on clinical indicators of hypovolemia (not albumin level alone). 2
Contraindications to Albumin Infusion
- First-line volume replacement in critically ill patients (excluding specific liver scenarios) 2
- Thermal injuries or ARDS 2
- Conjunction with diuretics for fluid removal 2
- Preterm neonates with respiratory distress 2
- Kidney replacement therapy for intradialytic hypotension 2
- Pediatric cardiovascular surgery 2
Albumin infusion carries significant risks: fluid overload, hypotension, hemodilution requiring transfusion, anaphylaxis, peripheral gangrene, and high cost (~$130/25g). 2
Monitoring and Follow-Up
For chronic kidney disease patients: Monitor serum albumin at least every 4 months, with a target ≥4.0 g/dL (bromocresol green method). 2 Evaluate in context of overall clinical status and inflammatory markers. 2
For dialysis patients: Monitor normalized protein nitrogen appearance (nPNA) with target ≥0.9 g/kg/day. 2
Serial albumin measurements should be interpreted alongside inflammatory markers, fluid status, and clinical trajectory rather than as isolated values. 1, 2
Common Pitfalls to Avoid
Do not assume hypoalbuminemia equals malnutrition. 1, 2 In hospitalized patients, inflammation and fluid overload are far more common causes than pure nutritional deficiency. 1
Do not administer albumin infusions to "correct" a low albumin number. 2 This approach is expensive, potentially harmful, and does not improve outcomes when the underlying cause is not addressed. 2
Do not use high-protein diets in nephrotic syndrome. 7, 8 This paradoxically worsens albumin depletion by increasing urinary losses. 7, 8
Do not ignore fluid status. 1, 3 Hemodilution from crystalloid administration is a reversible cause that requires diuresis, not albumin supplementation. 1